SERUM INSTITUTE OF INDIA PRIVATE LIMITED

SERUM INSTITUTE OF INDIA PRIVATE LIMITED is a factory.

Company Introduction:

Serum Institute of India Private Limited, often referred to as SIIPL, is a global biotechnology and biopharmaceutical company headquartered in Pune, India. Founded in 1966 by Dr. Cyrus Poonawalla, it has grown to become the world's largest vaccine manufacturer by number of doses produced and sold globally.

The company specializes in the production of life-saving immunobiologicals, including vaccines, antitoxins, and immunoglobulins. It plays a critical role in global public health by supplying affordable vaccines to over 170 countries, primarily through UNICEF, PAHO, and other global procurement agencies. Its vast portfolio includes vaccines for a wide range of diseases such as polio, diphtheria, tetanus, pertussis, Hib, measles, mumps, rubella, rotavirus, BCG, influenza, and more recently, COVID-19.

Serum Institute of India is dedicated to the mission of providing affordable vaccines to humanity, ensuring that even the poorest populations have access to essential immunizations. Its state-of-the-art manufacturing facilities adhere to stringent international quality standards, making it a pivotal player in disease prevention worldwide.

The following products are manufactured or sold by SERUM INSTITUTE OF INDIA PRIVATE LIMITED:

Covishield (Oxford-AstraZeneca COVID-19 vaccine)

Covovax (Novavax COVID-19 vaccine)

Polio vaccines (Oral Polio Vaccine and Inactivated Polio Vaccine)

Measles, Mumps, Rubella (MMR) vaccine

Diphtheria, Tetanus, Pertussis (DTwP and DTaP) vaccines

Hepatitis B vaccine

Haemophilus influenzae type b (Hib) vaccine

Rotavirus vaccine

Pneumococcal Conjugate Vaccine (Pneumosil)

Tetanus Toxoid (TT)

Rabies vaccine

Meningococcal ACWY vaccine

Typhoid Conjugate Vaccine (Typbar TCV)

Human Papillomavirus (HPV) vaccine (Cervavac)